ÂÜÀòÂÒÂ×

Nidal Boulos, PhD, CCRP, currently serves as the Director and Clinical Scientist at REGENXBIO Inc., focusing on first-in-human gene therapy products for neurodegenerative programs and collaborating with cross-functional teams on clinical studies. Previously, Nidal held multiple roles at St. Jude Children's Research Hospital, including Clinical Research Scientist II, Scientific Manager, Staff Scientist, and Postdoctoral Research Associate, where responsibilities included designing gene therapy protocols for complex hematological conditions, managing laboratory operations, overseeing clinical trials, and leading translational studies in ependymoma and leukemia. Nidal holds a PhD in Oncology from the Northern Institute for Cancer Research, a Master's in Human Medical Genetics and Immunology from Brunel University London, and a Bachelor's in Medical Laboratory Technology from the American University of Beirut.